跳至主要内容
临床试验/NCT01960543
NCT01960543已完成4 期

Comparison of the Effects of Bupivacaine or Levobupivacaine on Cerebral Oxygenation During Intrathecal Anesthesia in Elderly Patients Who Underwent Hip Fracture Repair

Corporacion Parc Tauli1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
58
试验地点
1
主要终点
Proportion of intraoperative time with a decrease of cerebral regional oxygen saturation (SrO2), of at least 20% with respect to baseline values

研究概览

简要总结

Elderly patients with hip fracture are frail due to associated comorbidity. In these situations, regional anesthesia is recommended as it is associated to less postoperative cognitive dysfunction. However, hypotension during the process may impair ischemic cardiopathy and induce a cerebrovascular stroke. Selection of the right anesthetic agent and the administration of vasoactive drugs during the process can minimize these risks. Although bupivacaine and levobupivacaine share pharmacokinetic and pharmacodynamic properties, the studies show conflicting results. The aim of this study is to investigate if there are clinically relevant differences between these two drugs in terms of hemodynamic parameters during the surgical process with special focus on the effects on regional cerebral oximetry and cognitive status after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 70 years old who undergo major surgery for hip fracture and will receive intrathecal anesthesia
  • Patients in which it is considered adequate, according to the usual clinical practice, the use of bupivacaine or levobupivacaine as part of the intrathecal anesthesia
  • Patients who give their informed consent to participate in the study

排除标准

  • Patients allergic to anesthetic drugs to be used in the protocol or to local anesthetics amida type.
  • Patients with severe aortic stenosis or hemodynamic instability.
  • Patients who refuse the anesthetic technique or contraindication for the use of the intrathecal technique.
  • Patients with severe cognitive impairment previous to the intervention (defined by a score in the Pfeiffer test of 8-10 errors)
  • Patients in which the use of bupivacaine or levobupivacaine is contraindicated as part of the intrathecal anesthesia
  • Any condition that, in the investigator's opinion, could pose a risk to the patient

研究组 & 干预措施

Bupivacaine

Active Comparator

Intrathecal administration of bupivacaine 0.5%

Doses:

Bupivacaine 7 mg plus fentanyl 15 ug for patients shorter than 160 cm. Bupivacaine 9 mg plus fentanyl 15 ug for patients equal or taller than 160 cm or hip replacement.

干预措施: fentanyl 15 microg (Drug)

Bupivacaine

Active Comparator

Intrathecal administration of bupivacaine 0.5%

Doses:

Bupivacaine 7 mg plus fentanyl 15 ug for patients shorter than 160 cm. Bupivacaine 9 mg plus fentanyl 15 ug for patients equal or taller than 160 cm or hip replacement.

干预措施: Bupivacaine 7 mg (Drug)

Bupivacaine

Active Comparator

Intrathecal administration of bupivacaine 0.5%

Doses:

Bupivacaine 7 mg plus fentanyl 15 ug for patients shorter than 160 cm. Bupivacaine 9 mg plus fentanyl 15 ug for patients equal or taller than 160 cm or hip replacement.

干预措施: Bupivacaine 9 mg (Drug)

Levobupivacaine

Active Comparator

Intrathecal administration of levobupivacaine 0.5%:

Doses:

Levobupivacaine 7 mg plus fentanyl 15 ug for patients shorter than 160 cm. Levobupivacaine 9 mg plus fentanyl 15 ug for patients equal or taller than 160 cm or hip replacement.

干预措施: fentanyl 15 microg (Drug)

Levobupivacaine

Active Comparator

Intrathecal administration of levobupivacaine 0.5%:

Doses:

Levobupivacaine 7 mg plus fentanyl 15 ug for patients shorter than 160 cm. Levobupivacaine 9 mg plus fentanyl 15 ug for patients equal or taller than 160 cm or hip replacement.

干预措施: Levobupivacaine 7 mg (Drug)

Levobupivacaine

Active Comparator

Intrathecal administration of levobupivacaine 0.5%:

Doses:

Levobupivacaine 7 mg plus fentanyl 15 ug for patients shorter than 160 cm. Levobupivacaine 9 mg plus fentanyl 15 ug for patients equal or taller than 160 cm or hip replacement.

干预措施: Levobupivacaine 9 mg (Drug)

结局指标

主要结局

Proportion of intraoperative time with a decrease of cerebral regional oxygen saturation (SrO2), of at least 20% with respect to baseline values

时间窗: Measured continuously during surgery (an expected average of 60 minutes)

次要结局

  • Change in cognitive function after 7 days with respect to preoperative function, measured by means of the Pfeiffer cognitive test(7 days post surgery)

研究者

发起方
Corporacion Parc Tauli
申办方类型
Other
责任方
Principal Investigator
主要研究者

Diana L Fernandez Galinski

Physician - Anesthesiology

Corporacion Parc Tauli

研究点 (1)

Loading locations...

相似试验

Effects of Bupivacaine and Levobupivacaine on... | 临床试验